$2.88
0.03[1.05%]
At close: Apr 25
$2.88
0[0.00%]
PreMarket: 4:53PM EDT
Mersana Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Mersana Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | MRSN | Q1 | -$0.52 | -$0.18 | — | — | $7.80M | $7.93M | — | — | Get Alert |
02/28/2024 | AM | MRSN | Q4 | -$0.44 | -$0.16 | -$0.16 | 0.00% | $14.69M | $14.77M | $10.70M | -27.55% | Get Alert |
11/07/2023 | AM | MRSN | Q3 | -$0.61 | -$0.36 | -$0.35 | 2.78% | $5.57M | $9.35M | $7.70M | -17.67% | Get Alert |
08/08/2023 | AM | MRSN | Q2 | -$0.55 | -$0.50 | -$0.47 | 6.00% | $4.28M | $8.45M | $10.65M | 26.08% | Get Alert |
05/09/2023 | AM | MRSN | Q1 | -$0.59 | -$0.44 | -$0.52 | -18.18% | $2.04M | $18.29M | $7.80M | -57.34% | Get Alert |
02/28/2023 | AM | MRSN | Q4 | -$0.68 | -$0.50 | -$0.44 | 12.00% | $11.00K | $15.28M | $14.69M | -3.87% | Get Alert |
11/07/2022 | AM | MRSN | Q3 | -$0.63 | -$0.09 | -$0.61 | -577.78% | $11.00K | $13.57M | $5.57M | -58.93% | Get Alert |
08/08/2022 | PM | MRSN | Q2 | -$0.59 | -$0.52 | -$0.55 | -5.77% | $11.00K | $2.18M | $4.28M | 96.51% | Get Alert |
05/09/2022 | AM | MRSN | Q1 | -$0.50 | -$0.32 | -$0.59 | -84.38% | $11.00K | — | $2.04M | — | Get Alert |
02/28/2022 | AM | MRSN | Q4 | -$0.42 | -$0.67 | -$0.68 | -1.49% | $10.00K | — | $11.00K | — | Get Alert |
11/09/2021 | AM | MRSN | Q3 | -$0.33 | -$0.58 | -$0.63 | -8.62% | $11.00K | $100.00K | $11.00K | -89.00% | Get Alert |
08/06/2021 | AM | MRSN | Q2 | -$0.33 | -$0.50 | -$0.59 | -18.00% | $796.00K | $140.00K | $11.00K | -92.14% | Get Alert |
05/10/2021 | PM | MRSN | Q1 | -$0.35 | -$0.39 | -$0.50 | -28.21% | $11.00K | — | $11.00K | — | Get Alert |
02/26/2021 | AM | MRSN | Q4 | -$0.34 | -$0.32 | -$0.42 | -31.25% | $42.00K | $170.00K | $10.00K | -94.12% | Get Alert |
11/09/2020 | AM | MRSN | Q3 | -$0.35 | -$0.30 | -$0.33 | -10.00% | $844.00K | — | $11.00K | — | Get Alert |
08/07/2020 | AM | MRSN | Q2 | -$0.36 | -$0.30 | -$0.33 | -10.00% | $202.00K | $300.00K | $796.00K | 165.33% | Get Alert |
05/08/2020 | AM | MRSN | Q1 | $0.70 | -$0.37 | -$0.35 | 5.41% | $41.03M | $390.00K | $11.00K | -97.18% | Get Alert |
02/28/2020 | AM | MRSN | Q4 | -$0.97 | -$0.38 | -$0.34 | 10.53% | $1.19M | $290.00K | $42.00K | -85.52% | Get Alert |
11/06/2019 | AM | MRSN | Q3 | -$0.75 | -$0.37 | -$0.35 | 5.41% | $2.15M | $290.00K | $844.00K | 191.03% | Get Alert |
Mersana Therapeutics (MRSN) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $-0.16, which hit the estimate of $-0.16.
The Actual Revenue was $10.7M, which missed the estimate of $14.8M.
Browse earnings estimates, EPS, and revenue on all stocks.